Trial intelligence / Profile preview

TCF vs TC vs ECF in Advanced Gastric Carcinoma

NCT00004873Phase 2Completed

Sponsor
Swiss Group for Clinical Cancer Research
Start
Aug 1999
Primary completion
Jul 2003
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of docetaxel in gastric cancer (GC), sponsored by Swiss Group for Clinical Cancer Research. Started Aug 1999; status: completed.

02

Drugs

docetaxel
03

Conditions

gastric cancer (GC)

Beyond the preview

Go deeper on NCT00004873.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00004873.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call